Publication date: Jun 26, 2025
New research uncovers how Akkermansia muciniphila primes powerful immune responses against the virus. Study: Akkermansia Muciniphila Primes Lung-Resident Antiviral Immunity via the GutLung Axis During SARS-CoV-2 Infection. The study also examined the therapeutic potential of the gut microbial community, with a specific focus on Akkermansia muciniphila. Furthermore, the study used antibiotic-treated mice as a pseudo-germ-free model (lacking true germ-free immunological naivety), which can potentially affect the colonization efficiency and immunomodulatory functions of Akkermansia muciniphila. The antibiotic pretreatment resulted in depletion of the gut microbiota. Importantly, Akkermansia muciniphila was administered prophylactically (before infection). The gut-lung axis is a bidirectional network that connects the gastrointestinal system with the respiratory system via various signaling pathways, immune cell trafficking, and microbial metabolites. These mice exhibit neurotropism and lethality patterns differing from human cases, limiting clinical extrapolation. Future studies should consider these factors while investigating the immunomodulatory mechanisms of this bacterium and should evaluate therapeutic (post-infection) administration.
| Concepts | Keywords |
|---|---|
| Coronavirus | Akkermansia |
| Diabetes | Bacterium |
| Korea | Cov |
| Lethal | Covid |
| Probiotics | Findings |
| Gut | |
| Immune | |
| Infection | |
| Lung | |
| Microbial | |
| Microbiota | |
| Muciniphila | |
| Sars | |
| Specific | |
| Study |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | IDO | commensal |
| disease | MESH | obesity |
| disease | IDO | role |
| disease | MESH | infection |
| disease | IDO | pathogen |
| disease | MESH | infectious diseases |
| disease | IDO | host |
| disease | MESH | weight loss |
| disease | IDO | cell |
| disease | MESH | dysbiosis |
| pathway | KEGG | Steroid biosynthesis |
| disease | IDO | immune response |
| drug | DRUGBANK | Omega-3 fatty acids |
| disease | MESH | inflammation |
| disease | IDO | production |
| disease | IDO | intervention |
| disease | MESH | respiratory infections |